NICE approval for newest SGLT2 inhibitor in diabetes

Patients with type II diabetes will be able to get treatment with empagliflozin (Jardiance) on the NHS, NICE has ruled.

Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that prevents glucose reuptake in the kidney, leading to the excretion of excess glucose in the urine.
Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that prevents glucose reuptake in the kidney, leading to the excretion of excess glucose in the urine.

The SGLT2 inhibitor empagliflozin has been recommended by NICE as an option for the same uses as canagliflozin (Invokana). 

Empagliflozin in a dual therapy regimen in combination with metformin is accepted as an option for treating type II diabetes when a sulfonylurea is contraindicated or not tolerated, or the person is at significant risk of hypoglycaemia or its consequences.

Further information
NICE technology appraisal TA336

It is also accepted for use in a triple therapy regimen in combination with metformin and either a sulfonylurea or a thiazolidinedione (glitazone), and for use in combination with insulin with or without other antidiabetic drugs.

The other SGLT2 inhibitor dapagliflozin (Forxiga) is recommended by NICE as an option for dual therapy in combination with metformin, but not as triple therapy.


MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.